Cibus, Inc. (NASDAQ:CBUS) Short Interest Update

Cibus, Inc. (NASDAQ:CBUS) saw a significant increase in short interest in November. As of November 15th, there was short interest totalling 1,950,000 shares, an increase of 5.4% from the October 31st total of 1,850,000 shares. Currently, 10.5% of the company’s stock are short sold. Based on an average trading volume of 211,500 shares, the short-interest ratio is presently 9.2 days.

Cibus Price Performance

CBUS traded down $0.20 during mid-day trading on Tuesday, hitting $4.52. 37,983 shares of the stock were exchanged, compared to its average volume of 134,992. The firm’s fifty day moving average is $4.00 and its two-hundred day moving average is $7.30. Cibus has a 1-year low of $2.86 and a 1-year high of $23.18.

Analyst Upgrades and Downgrades

A number of equities research analysts have recently commented on the stock. Alliance Global Partners dropped their price objective on shares of Cibus from $25.00 to $23.50 and set a “buy” rating on the stock in a research note on Tuesday, September 24th. HC Wainwright restated a “buy” rating and issued a $25.00 target price on shares of Cibus in a report on Monday, November 11th. Finally, Canaccord Genuity Group restated a “buy” rating and issued a $20.00 target price on shares of Cibus in a research report on Tuesday, October 22nd.

Institutional Inflows and Outflows

A number of institutional investors have recently made changes to their positions in CBUS. Old West Investment Management LLC raised its holdings in shares of Cibus by 3.6% in the 2nd quarter. Old West Investment Management LLC now owns 53,247 shares of the company’s stock valued at $524,000 after purchasing an additional 1,868 shares in the last quarter. HighTower Advisors LLC increased its position in Cibus by 20.6% in the 3rd quarter. HighTower Advisors LLC now owns 16,125 shares of the company’s stock valued at $52,000 after acquiring an additional 2,750 shares during the period. FineMark National Bank & Trust grew its stake in shares of Cibus by 24.3% in the 2nd quarter. FineMark National Bank & Trust now owns 20,488 shares of the company’s stock valued at $202,000 after purchasing an additional 4,000 shares during the last quarter. Charles Schwab Investment Management Inc. increased its holdings in shares of Cibus by 14.6% in the third quarter. Charles Schwab Investment Management Inc. now owns 49,285 shares of the company’s stock valued at $161,000 after purchasing an additional 6,276 shares during the period. Finally, SG Americas Securities LLC purchased a new stake in shares of Cibus during the third quarter worth approximately $33,000. Institutional investors and hedge funds own 33.81% of the company’s stock.

About Cibus

Cibus, Inc, a agricultural biotechnology company, develops and licenses plant traits to seed companies for royalties. The company primarily focus on trait productivity in two areas, including productivity traits that enable farmers to have higher yields and reduce the use of the crop protection chemicals and fertilizers; and sustainable ingredients that enable corporations to replace ingredients that are fossil fuel based or whose production results in increased greenhouse gases.